Popular procedures without evidence of benefit: A case study of percutaneous coronary intervention for stable

Vinay Guduguntla1, Rita F Redberg2

  • 1Department of Medicine, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA, 94131, United States.

Insights

Percutaneous coronary intervention (PCI) is frequently used for stable coronary artery disease (CAD) despite limited benefits. Optimal medical therapy (OMT) and lifestyle changes are underutilized, indicating a need for practice alignment with evidence-based care.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Services Research

Background:

  • Percutaneous coronary intervention (PCI) is commonly performed in stable coronary artery disease (CAD) despite evidence of limited benefit.
  • Utilization rates of PCI are increasing in Europe and often exceed those in the U.S.
  • Optimal medical therapy (OMT) and lifestyle modifications remain underutilized as first-line treatments for stable CAD.

Purpose of the Study:

  • To review the evidence comparing PCI to OMT in stable CAD.
  • To analyze utilization patterns of PCI in stable CAD.
  • To identify interventions for aligning clinical practice with evidence-based recommendations.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) and systematic reviews.
  • Analysis of appropriate use criteria (AUC) and professional society guidelines.
  • Examination of PCI utilization data and trends.

Main Results:

  • Evidence suggests limited incremental benefit of PCI over OMT in stable CAD.
  • PCI is often performed for uncertain or inappropriate indications.
  • Significant disparities exist in PCI utilization rates across countries.

Conclusions:

  • Current practice for stable CAD often deviates from evidence-based recommendations.
  • There is a critical need to promote OMT and lifestyle changes.
  • Interventions are required to optimize PCI use and improve patient outcomes in stable CAD.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
71
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
66
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
282
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
56
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
53
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
47